By healing the gut lining, reducing intestinal permeability, and modulating gut inflammation, BPC-157 addresses the peripheral inflammatory signaling that contributes to central neuroinflammation and depressive symptoms
The maximum approved dose produces the greatest weight loss in clinical trials but also the highest side effect incidence
These emerging treatment options offer hope for individuals with IC, providing avenues for personalized and effective symptom management
ERG is a very good cytoprotecting agent against various cellular insults (Borodina et al
In agreement, we observed that cellular GSH levels and the ratio of GSH/GSSG were increased in DMF treatment group (Fig
PubMed Chang CH, Tsai WC, Lin MS, et al